Skip to main content
. 2025 May 21;41(5):437–453. doi: 10.1007/s43188-025-00296-x

Table 3.

Induction of PCOS by androgens and hormones and associated histological alterations

S. No Chemical name Species Dose Route & exposure duration Findings References
1 Estradiol valerate Wistar Kyoto rat (adult virgin) 4 mg Intramuscular injection (single dose) Many atretic follicles and regressed corpora lutea.  [65]
2 Cortisone B6A mice (neonatal) 20 μg

Subcutaneous injection

(3–6 days)

Ovaries lacked corpora lutea and multiple follicular cysts were present.  [66]
3 Estrogen Mice 20 μg

Subcutaneous injection

(15 days)

Follicular cysts formed and caused anovulation.

Corpora luteum was absent. 

[67]
4 Dihydrot-estostero-ne (DHT) Mice 250 μg

Subcutaneous injection

(16–18 days of gestation)

Large number of small antral follicles in ovary, thin granulosa cell layer within follicle and thick theca cell layer.  [43]
5 Testoster-one + high fat diet Wistar rat

1 mg/

100 g b.wt

Subcutaneous injection (28 days) Many preantral, atretic, and cystic follicles along with enlargement of stroma.  [68]
6 Testoster-one Sprague Dawley rat 2.5 mg/d Subcutaneous injection Increase in cystic, atretic, and preantral follicles. Decrease in corpora lutea.  [69]
7 DHT mice 10 mg Subcutaneous implant (90 days) Numerous multicystic follicles.  [36]
8 DHEA + High-fat diet C57BL/6 Mice

6 mg/

100 g b.wt + 60% high-fat diet

Subcutaneous injection (20 days) + oral diet More cystic and antral follicles and reduced corpora lutea.  [37]
9 Mifeprist-one (Antiprog-esterone) (RU486) Wistar rat

5 mg,

7.5 mg, &

10 mg

Subcutaneous

Injection

(9 days)

Enlarged ovaries with arrested follicular development. 

Increased atretic follicular cysts and hypertrophy of granulosa cells. 

[70]
10 Letrozole C57BL/6N female mice 50 μg/d Subcutaneous injection (5 weeks)

Irregular estrous cycle. 

Many cysts in ovaries were observed. 

[44]
11 Letrozole Sprague Dawley rats

1 mg/

kg/d

Oral (15 days) Increase in number of cystic and atretic follicles. Decreased corpus luteum and increased thickness of peripheral theca layer.  [71]
12 Dehydroe-piandrost-erone (DHEA) Naval Medical Research Institute (NMRI) rat 6 mg/kg.b.wt Intraperitoneal injection (20 days) Increased number of cystic follicles, decreased number of antral follicles and corpus luteum, and anovulation.  [72]
13 Insulin + Human chorionic gonadotr-opin (hCG) Sprague Dawley rat (70 days old) Insulin 0.5 to 6 IU/d + hCG3 IU/d Subcutaneous injection (twice daily for 23 days) Decrease in luminal epithelial cell numbers and layers, glands and gland conglomerates, and decrease in endometrium and myometrium.  [73]
14 DHEA C57BL/6 mice 6 mg/100 g.b.wt Subcutaneous injection (20 days) Reduction in healthy antral follicles, oocyte, and corpora lutea. Also, granulosa layer of follicles appears thin and degenerated.  [74]
15 DHEA Sprague Dawley rat 6 mg/100 g.b.wt Subcutaneous injection (4 weeks) Increased number of multiple follicular cysts and increased weight of ovary.  [45]
16 Human chorionic gonadotr-opin + insulin Sprague Dawley rat 3 IU/d (hCG) & 0.5–3 U/d insulin

Subcutaneous injection

(22 days)

Numerous cystic follicles, degenerated granulosa cell layer, and reduced corpora lutea.  [75]
17 DHT C57Bl/6 J female mice 10 mg DHT + diets varied in protein, carbs, and fat content 1 cm SILASTIC brand DHT implant (10 weeks) Decrease and lack of corpora lutea.  [76]
18 Testoster-one Zebra fish 0.25, 2, 10, & 100 ng/mL Dissolved in swimming water (3 days) Arrest in follicular growth, oligo-ovulation, and ovarian enlargement.  [77]
19 DHEA Sprague Dawley 7 mg/ kg. b.wt Subcutaneous injection (90 days) Higher number of cystic and atretic follicles, hyperthecosis of internal cell layer, and thinning of the ganulosa layer.  [78]
20 Estradiol valerate Wistar rats 4 mg subcutaneous injection (single administration)

Reduction in size of ovary, increased size of cysts,

degenerative secondary follicles were present, and

Corpus lutea absent. 

[46]
21 DHT Sprague Dawley 83 µg/d/kg.b.wt Subcutaneous injection (90 days) Larger antral follicles, thickened theca interna, multiple cystic follicles lacking antrum and corpus lutea, and reduction in endometrium thickness.  [78]